about
Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinomaCirculating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma.Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression.Genome-wide DNA methylation profiles in hepatocellular carcinoma.Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure.Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma.Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.Development of risk scoring system for stratifying population for hepatocellular carcinoma screening.A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan.Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.Hepatitis B viraemia: its heritability and association with common genetic variation in the interferon gamma signalling pathway.Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma.Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.IL28B: relevance extended to hepatitis B virus or limited to interferon-based therapies in hepatitis C virus?Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.Body-mass index and progression of hepatitis B: a population-based cohort study in men.Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men.Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levelsInfluences of tobacco and alcohol use on hepatocellular carcinoma survivalLocalization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic areaRole of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related riskAndrogen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in womenL-myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriersCytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinomaEffect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in TaiwanA p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriersIncreased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern TaiwanAflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patientsIdentification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers
P50
Q28392002-74F069F5-16A3-40AA-A803-A6B192D7F5C0Q34576356-89A4AE53-1409-4DE7-9EE1-EF1D54F3870DQ34922094-E555F36E-5CED-4596-8E23-93076E9AC622Q35899166-8664632E-713C-48A2-A6BF-4E41F9814532Q36002022-EA85089A-9C41-4A89-895C-D4538CD5CBCDQ38677390-FDE8BBE6-2D9C-43CF-8871-9F3647E6C1EAQ39733935-6DBAE193-1F37-4000-91A2-E594C0DC4015Q40141021-0413E26C-7D14-4E16-8DBC-13EB3F492F22Q40722555-0666882C-0B31-480F-8C15-A73098985D81Q41651668-7156DF81-54FB-4A1D-BF66-837A757AC7B7Q43036233-B110C432-ADA2-48EE-8CED-1D2B9B8F1289Q43664978-816DE9B4-DE43-4F18-BE23-D93446C395EFQ44241611-41EABBF7-902F-46DD-ACA0-ECA68D253F1EQ44602972-6722211F-8760-4DB4-A6CD-F8296D2AB832Q44903686-0520759E-B4E2-462C-9FBD-701D2D188582Q45361646-F95E31E5-9CBB-4052-8583-A94447F92CD7Q45382207-CE5AF0E7-A487-4734-86A4-54E14EC74B76Q45511057-D530EC2B-EBCE-4FD9-A84D-0AED3574A603Q46291527-E8B35EAF-FE1B-4254-A973-B2FFC0F2EF7DQ46902014-391B22FD-9594-4F06-82A7-67117AB39150Q57205352-B031A3F4-ED5A-4B3E-AA26-EA79B05A076BQ58814437-F1DA7359-9F33-49D8-9957-4E7646CBE676Q58814520-16684A96-BB7E-445F-AD6C-9EBA64324CF2Q58814554-0B72AFAB-F44D-4BFF-A8AC-13F66733E48EQ58814559-44308B23-898C-474B-A44E-26FF2D66815EQ71089214-C79FFB55-C151-43BC-AFD3-EF366D4A4761Q71737236-F47ECC13-B5CF-48C2-9099-FEEC88133B94Q73677300-F8E3E74C-B160-4BDC-A770-E298E8C6875AQ74529921-0847DDBB-F376-4606-A433-CE486CD19323Q78525470-0C1B6672-F824-4A53-AE4F-1652D8C9E150Q82997793-C5608B1E-7D3A-422A-AF42-0FE5940C6132Q84845420-B63E7FA6-3665-415E-95D1-E7AD744B7184
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ming-Whei Yu
@ast
Ming-Whei Yu
@en
Ming-Whei Yu
@es
Ming-Whei Yu
@nl
Ming-Whei Yu
@sl
于明暉
@zh
type
label
Ming-Whei Yu
@ast
Ming-Whei Yu
@en
Ming-Whei Yu
@es
Ming-Whei Yu
@nl
Ming-Whei Yu
@sl
于明暉
@zh
prefLabel
Ming-Whei Yu
@ast
Ming-Whei Yu
@en
Ming-Whei Yu
@es
Ming-Whei Yu
@nl
Ming-Whei Yu
@sl
于明暉
@zh
P1048
P106
P1153
7404272827
P2038
Ming-Whei_Yu
P214
13150202073803111188
P31
P496
0000-0002-8371-6236
P7859
viaf-13150202073803111188